← Advanced Bronchoscopy

Histopathological correlates of endobronchial OCT airway features in patients with COPD

IPBronch Review

🎯 Background & Rationale

  • Endobronchial OCT utility: Endobronchial optical coherence tomography provides high-resolution, in vivo cross-sectional imaging of airway microstructure in chronic obstructive pulmonary disease.
  • Microstructural interpretation gap: While candidate biomarkers like luminal mucus, edema patterns, and mucosal buckling are visualized, their exact histological substrates remain poorly defined.
  • Translational validation need: Establishing airway-level correlations between endobronchial optical coherence tomography features and histopathology is essential for biological validation in interventional pulmonology.

👥 Study Design & Population

  • Prospective observational cohort: This was an exploratory imaging-histopathology correlation study evaluating 26 patients with chronic obstructive pulmonary disease undergoing surgical lung resection.
  • Participant characteristics: The cohort had a mean age of 57.4 ± 8.2 years, 92.3% were ever-smokers, and the mean post-bronchodilator forced expiratory volume in 1 second was 68.9% ± 19.3% predicted.
  • Airflow limitation severity: Most patients presented with Global Initiative for Chronic Obstructive Lung Disease grade 1 or 2 airflow limitation (84.6%), with 15.3% in grades 3 to 4.

📈 Methodology & Rigor

  • Preoperative imaging protocol: In vivo endobronchial optical coherence tomography pullbacks (5.4 cm length, 540 frames) were acquired in targeted segmental bronchi prior to surgical resection.
  • Anatomical specimen matching: Resected airways were dissected into ten transverse blocks, stained with hematoxylin and eosin, and matched with optical coherence tomography parameters at the airway level.
  • Blinded independent analysis: Image measurements and histopathological scorings (including Reid index, composite inflammatory score, and airway smooth muscle area fraction) were performed independently by blinded observers.

🔬 Key Findings [or Planned Endpoints]

  • Mucus and Reid index: Mean mucus area fraction and mucus-positive frame proportion correlated strongly with the Reid index (Spearman rho = 0.850 and rho = 0.711, respectively; both P < 0.001).
  • Edema and inflammation: The edema-positive frame proportion correlated significantly with the composite inflammatory score (Spearman rho = 0.772, P < 0.001).
  • Buckling and smooth muscle: Mean buckling length fraction and buckling-positive frame proportion correlated strongly with airway smooth muscle area fraction (Spearman rho = 0.895 and rho = 0.896, respectively; P < 0.001).
  • Adjusted multivariable models: After adjusting for age, pack-years, and Global Initiative for Chronic Obstructive Lung Disease grade, mucus-Reid and buckling-smooth muscle associations remained significant (adjusted P <= 0.038), while the edema-inflammation association attenuated (adjusted P = 0.794).

⚖️ Critical Appraisal

  • Small surgical cohort: The study relied on a single-center cohort of 26 patients, predominantly with mild-to-moderate disease, limiting broader clinical generalizability.
  • Spatial matching limitations: Complete point-to-point spatial overlap between in vivo optical coherence tomography and formalin-fixed histological sections could not be guaranteed.
  • Multicollinearity concerns: Multivariable linear regression models demonstrated moderate-to-high multicollinearity (variance inflation factors 8.71 to 9.46), making adjusted estimates exploratory.

💡 The Clinical Bottom Line

  • Biological validation: Endobronchial optical coherence tomography reliably visualizes structural airway changes that correspond directly to underlying secretory, inflammatory, and smooth muscle remodeling in chronic obstructive pulmonary disease.
  • Translational confidence: Bronchoscopists can interpret distinct optical coherence tomography phenotypes—such as luminal mucus and mucosal buckling—as reflective of true histological pathology rather than artifacts.
  • Future clinical utility: Longitudinal and multicenter studies are still required to determine whether these validated imaging biomarkers can effectively monitor disease progression or therapeutic responses.

Abstract not available.
Read the full paper ↗

Keep reading

N opens the next one